Lexogen’s new SENSE mRNA-Seq kit gives researchers the power to analyze antisense transcription like never before. By eliminating the causes of false-positive antisense reads, SENSE delivers unprecedented strand-specificity (>99.9%) and gives you the confidence that every antisense read originates from an antisense transcript.
Lexogen is eager to work with you on exciting projects. We therefore invite you to submit a research proposal in which you describe how you would take advantage of the extreme strand-specificity that SENSE provides. The winning proposals will be completely supported by Lexogen (this includes sample preparation, sequencing, and any required bioinformatical support).
Please apply by sending your project proposal and short description of your research interests to [email protected]. The application deadline is March 31st, 2013. Proposals will be reviewed by an in-house committee and winners will be announced on April 8th.
For more information about SENSE please visit our website www.lexogen.com, contact us under +43 (1) 345 1212-41 or at [email protected].
Lexogen is eager to work with you on exciting projects. We therefore invite you to submit a research proposal in which you describe how you would take advantage of the extreme strand-specificity that SENSE provides. The winning proposals will be completely supported by Lexogen (this includes sample preparation, sequencing, and any required bioinformatical support).
Please apply by sending your project proposal and short description of your research interests to [email protected]. The application deadline is March 31st, 2013. Proposals will be reviewed by an in-house committee and winners will be announced on April 8th.
For more information about SENSE please visit our website www.lexogen.com, contact us under +43 (1) 345 1212-41 or at [email protected].
Comment